ArticleJournal of cheminformatics2016
Similar compounds versus similar conformers: complementarity between PubChem 2-D and 3-D neighboring sets.
Article in Journal of cheminformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- iRGD-functionalized PLGA nanocomplex co-loaded with paclitaxel and Trametes robiniophila Murr for targeted inhibition of chemoresistant and metastatic signaling gene PDCD4 in colon cancer.BMC pharmacology & toxicology · 2026Article
- In silico discovery of thioglycoside analogues as donor-site inhibitors of glycosyltransferase LgtC.Scientific reports · 2026Article
- Optimizing skin sensitization prediction across activity cliffs: a comparative analysis of K-nearest neighbours vs random Forest.Frontiers in toxicology · 2026Article
- A resource description framework (RDF) model of named entity co-occurrences in biomedical literature and its integration with PubChemRDF.Journal of cheminformatics · 2025Article
- In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains.International journal of molecular sciences · 2025Article
- Interpretable AI and Machine Learning Classification for Identifying High-Efficiency Donor-Acceptor Pairs in Organic Solar Cells.ACS omega · 2024Article
- Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins.Journal of medicinal chemistry · 2024Article
- Exploring Chemical Information in PubChem.Current protocols · 2021Article
- Identification of high affinity and low molecular alternatives of boceprevir against SARS-CoV-2 main protease: A virtual screening approach.Chemical physics letters · 2021Article
- Applications of Virtual Screening in Bioprospecting: Facts, Shifts, and Perspectives to Explore the Chemo-Structural Diversity of Natural Products.Frontiers in chemistry · 2021Review
- PUG-View: programmatic access to chemical annotations integrated in PubChem.Journal of cheminformatics · 2019Article
- An update on PUG-REST: RESTful interface for programmatic access to PubChem.Nucleic acids research · 2018Article
- Finding Potential Multitarget Ligands Using PubChem.Methods in molecular biology (Clifton, N.J.) · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPubChem is a public repository for biological activities of small molecules. For the efficient use of its vast amount of chemical information, PubChem performs 2-dimensional (2-D) and 3-dimensional (3-D) neighborings, which precompute "neighbor" relationships between molecules in the PubChem Compound database, using the PubChem subgraph fingerprints-based 2-D similarity and the Gaussian-shape overlay-based 3-D similarity, respectively. These neighborings allow PubChem to provide the user with immediate access to the list of 2-D and 3-D neighbors (also called "Similar Compounds" and "Similar Conformers", respectively) for each compound in PubChem. However, because 3-D neighboring is much more time-consuming than 2-D neighboring, how different the results of the two neighboring schemes are is an important question, considering limited computational resources.
resultsThe present study analyzed the complementarity between the PubChem 2-D and 3-D neighbors. When all compounds in PubChem were considered, the overlap between 2-D and 3-D neighbors was only 2% of the total neighbors. For the data sets containing compounds with annotated information, the overlap increased as the data sets became smaller. However, it did not exceed 31% and substantial fractions of neighbors were still recognized by either PubChem 2-D or 3-D similarity, but not by both. The Neighbor Preference Index (NPI) of a molecule for a given data set was introduced, which quantified whether a molecule had more 2-D or 3-D neighbors in the data set. The NPI histogram for all PubChem compounds had a bimodal shape with two maxima at NPI = ±1 and a minimum at NPI = 0. However, the NPI histograms for the subsets containing compounds with annotated information had a greater fraction of compounds with a strong preference for one neighboring method to the other (at NPI = ±1) as well as compounds with a neutral preference (at NPI = 0).
conclusionThe results of our study indicate that, for the majority of the compounds in PubChem, their structural similarity to other compounds can be recognized predominantly by either 2-D or 3-D neighborings, but not by both, showing a strong complementarity between 2-D and 3-D neighboring results. Therefore, despite its heavy requirements for computational resources, 3-D neighboring provides an alternative way in which the user can instantly access structurally similar molecules that cannot be detected if only 2-D neighboring is used.Graphical AbstractThe binned distribution of the neighbor preference indices (NPIs) for all compounds in PubChem (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.